UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK/SEMA3E suppression

Abstract Loss-of-function mutations at the retinoblastoma (RB1) gene are associated with increased mortality, metastasis, and poor therapeutic outcome in several cancers, including osteosarcoma. However, the mechanism(s) through which RB1 loss worsens clinical outcome remains understudied. Ubiquitin...

Full description

Bibliographic Details
Main Authors: Stephanie C. Wu, Ahhyun Kim, Yijun Gu, Daniel I. Martinez, Loredana Zocchi, Claire C. Chen, Jocelyne Lopez, Kelsey Salcido, Sarah Singh, Jie Wu, Ali Nael, Claudia A. Benavente
Format: Article
Language:English
Published: Nature Publishing Group 2022-09-01
Series:Oncogenesis
Online Access:https://doi.org/10.1038/s41389-022-00430-6
_version_ 1828178331450736640
author Stephanie C. Wu
Ahhyun Kim
Yijun Gu
Daniel I. Martinez
Loredana Zocchi
Claire C. Chen
Jocelyne Lopez
Kelsey Salcido
Sarah Singh
Jie Wu
Ali Nael
Claudia A. Benavente
author_facet Stephanie C. Wu
Ahhyun Kim
Yijun Gu
Daniel I. Martinez
Loredana Zocchi
Claire C. Chen
Jocelyne Lopez
Kelsey Salcido
Sarah Singh
Jie Wu
Ali Nael
Claudia A. Benavente
author_sort Stephanie C. Wu
collection DOAJ
description Abstract Loss-of-function mutations at the retinoblastoma (RB1) gene are associated with increased mortality, metastasis, and poor therapeutic outcome in several cancers, including osteosarcoma. However, the mechanism(s) through which RB1 loss worsens clinical outcome remains understudied. Ubiquitin-like with PHD and Ring Finger domains 1 (UHRF1) has been identified as a critical downstream effector of the RB/E2F signaling pathway that is overexpressed in various cancers. Here, we determined the role and regulatory mechanisms of UHRF1 in rendering osteosarcoma cells more aggressive. Higher UHRF1 expression correlated with malignancy in osteosarcoma cell lines, clinical samples, and genetically engineered mouse models. Gain- and loss-of-function assays revealed that UHRF1 has cell-intrinsic and extrinsic functions promoting cell proliferation, migration, invasion, angiogenesis, and metastasis. UHRF1 overexpression induced angiogenesis by suppressing AMPK activation and Semaphorin 3E (SEMA3E) expression. Further, UHRF1-mediated migration and metastasis resulted, at least in part, through altered expression of extracellular vesicles and their cargo, including urokinase-type plasminogen activator (uPA). Novel osteosarcoma genetically engineered mouse models confirmed that knocking out Uhrf1 considerably decreased metastasis and reversed the poorer survival associated with Rb1 loss. This presents a new mechanistic insight into RB1 loss-associated poor prognosis and novel oncogenic roles of UHRF1 in the regulation of angiogenesis and exosome secretion, both critical for osteosarcoma metastasis. This provides substantial support for targeting UHRF1 or its downstream effectors as novel therapeutic options to improve current treatment for osteosarcoma.
first_indexed 2024-04-12T05:14:26Z
format Article
id doaj.art-03dd0841ee8948ffa1fd264bf58aa27d
institution Directory Open Access Journal
issn 2157-9024
language English
last_indexed 2024-04-12T05:14:26Z
publishDate 2022-09-01
publisher Nature Publishing Group
record_format Article
series Oncogenesis
spelling doaj.art-03dd0841ee8948ffa1fd264bf58aa27d2022-12-22T03:46:40ZengNature Publishing GroupOncogenesis2157-90242022-09-0111111210.1038/s41389-022-00430-6UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK/SEMA3E suppressionStephanie C. Wu0Ahhyun Kim1Yijun Gu2Daniel I. Martinez3Loredana Zocchi4Claire C. Chen5Jocelyne Lopez6Kelsey Salcido7Sarah Singh8Jie Wu9Ali Nael10Claudia A. Benavente11Department of Pharmaceutical Sciences, University of CaliforniaDepartment of Pharmaceutical Sciences, University of CaliforniaDepartment of Pharmaceutical Sciences, University of CaliforniaDepartment of Developmental and Cell Biology, University of CaliforniaDepartment of Pharmaceutical Sciences, University of CaliforniaDepartment of Pharmaceutical Sciences, University of CaliforniaDepartment of Developmental and Cell Biology, University of CaliforniaDepartment of Developmental and Cell Biology, University of CaliforniaDepartment of Developmental and Cell Biology, University of CaliforniaDepartment of Biological Chemistry, University of CaliforniaDepartment of Pathology, University of CaliforniaDepartment of Pharmaceutical Sciences, University of CaliforniaAbstract Loss-of-function mutations at the retinoblastoma (RB1) gene are associated with increased mortality, metastasis, and poor therapeutic outcome in several cancers, including osteosarcoma. However, the mechanism(s) through which RB1 loss worsens clinical outcome remains understudied. Ubiquitin-like with PHD and Ring Finger domains 1 (UHRF1) has been identified as a critical downstream effector of the RB/E2F signaling pathway that is overexpressed in various cancers. Here, we determined the role and regulatory mechanisms of UHRF1 in rendering osteosarcoma cells more aggressive. Higher UHRF1 expression correlated with malignancy in osteosarcoma cell lines, clinical samples, and genetically engineered mouse models. Gain- and loss-of-function assays revealed that UHRF1 has cell-intrinsic and extrinsic functions promoting cell proliferation, migration, invasion, angiogenesis, and metastasis. UHRF1 overexpression induced angiogenesis by suppressing AMPK activation and Semaphorin 3E (SEMA3E) expression. Further, UHRF1-mediated migration and metastasis resulted, at least in part, through altered expression of extracellular vesicles and their cargo, including urokinase-type plasminogen activator (uPA). Novel osteosarcoma genetically engineered mouse models confirmed that knocking out Uhrf1 considerably decreased metastasis and reversed the poorer survival associated with Rb1 loss. This presents a new mechanistic insight into RB1 loss-associated poor prognosis and novel oncogenic roles of UHRF1 in the regulation of angiogenesis and exosome secretion, both critical for osteosarcoma metastasis. This provides substantial support for targeting UHRF1 or its downstream effectors as novel therapeutic options to improve current treatment for osteosarcoma.https://doi.org/10.1038/s41389-022-00430-6
spellingShingle Stephanie C. Wu
Ahhyun Kim
Yijun Gu
Daniel I. Martinez
Loredana Zocchi
Claire C. Chen
Jocelyne Lopez
Kelsey Salcido
Sarah Singh
Jie Wu
Ali Nael
Claudia A. Benavente
UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK/SEMA3E suppression
Oncogenesis
title UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK/SEMA3E suppression
title_full UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK/SEMA3E suppression
title_fullStr UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK/SEMA3E suppression
title_full_unstemmed UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK/SEMA3E suppression
title_short UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK/SEMA3E suppression
title_sort uhrf1 overexpression promotes osteosarcoma metastasis through altered exosome production and ampk sema3e suppression
url https://doi.org/10.1038/s41389-022-00430-6
work_keys_str_mv AT stephaniecwu uhrf1overexpressionpromotesosteosarcomametastasisthroughalteredexosomeproductionandampksema3esuppression
AT ahhyunkim uhrf1overexpressionpromotesosteosarcomametastasisthroughalteredexosomeproductionandampksema3esuppression
AT yijungu uhrf1overexpressionpromotesosteosarcomametastasisthroughalteredexosomeproductionandampksema3esuppression
AT danielimartinez uhrf1overexpressionpromotesosteosarcomametastasisthroughalteredexosomeproductionandampksema3esuppression
AT loredanazocchi uhrf1overexpressionpromotesosteosarcomametastasisthroughalteredexosomeproductionandampksema3esuppression
AT clairecchen uhrf1overexpressionpromotesosteosarcomametastasisthroughalteredexosomeproductionandampksema3esuppression
AT jocelynelopez uhrf1overexpressionpromotesosteosarcomametastasisthroughalteredexosomeproductionandampksema3esuppression
AT kelseysalcido uhrf1overexpressionpromotesosteosarcomametastasisthroughalteredexosomeproductionandampksema3esuppression
AT sarahsingh uhrf1overexpressionpromotesosteosarcomametastasisthroughalteredexosomeproductionandampksema3esuppression
AT jiewu uhrf1overexpressionpromotesosteosarcomametastasisthroughalteredexosomeproductionandampksema3esuppression
AT alinael uhrf1overexpressionpromotesosteosarcomametastasisthroughalteredexosomeproductionandampksema3esuppression
AT claudiaabenavente uhrf1overexpressionpromotesosteosarcomametastasisthroughalteredexosomeproductionandampksema3esuppression